These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6459224)

  • 1. Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Dec; 22(6):423-60. PubMed ID: 6459224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.
    Funk EA; Strausbaugh LJ
    Pharmacotherapy; 1982; 2(4):185-96. PubMed ID: 6221236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone (Cefobid, Pfizer).
    Lyon JA
    Drug Intell Clin Pharm; 1983 Jan; 17(1):7-11. PubMed ID: 6218974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Apr; 17(4):233-66. PubMed ID: 37064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory evaluation of cefoperazone.
    Sarver DK; Christensen GD; Hester MG; Ling FW; Pate JW; Rosenberg EW; Anderson GD; Bisno AL
    Clin Ther; 1981; 4(3):164-74. PubMed ID: 6458360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
    Daschner FD; Steffens A; Mählmann M; Metzger M
    Arzneimittelforschung; 1982; 32(5):531-3. PubMed ID: 6213241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Heel RC
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.
    Fukasawa M; Noguchi H; Okuda T; Komatsu T; Yano K
    Antimicrob Agents Chemother; 1983 Feb; 23(2):195-200. PubMed ID: 6601470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide clinical experience with cefoperazone.
    Gerber AU; Craig WA
    Drugs; 1981; 22 Suppl 1():108-18. PubMed ID: 6456884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.
    Kato M; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):721-7. PubMed ID: 6983860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third generation cephalosporins.
    Donowitz GR
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
    Miles HM; Carson M; Pavillard ER
    Drugs; 1981; 22 Suppl 1():15-9. PubMed ID: 6456885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with cefoperazone in biliary tract infections.
    Mashimo K
    Drugs; 1981; 22 Suppl 1():100-7. PubMed ID: 6456883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of cefoperazone-sulbactam].
    Zhang Y; Zhang J; Zhou L
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.
    Thornsberry C; Jones RN
    Drugs; 1981; 22 Suppl 1():3-12. PubMed ID: 6456889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.